SkinHealth Systems Inc. Class A Common Stock (SKIN) Stock Price

SKINStock

$10.56−63.33%52W

Market Cap$68.71M

P/E—

PEG Ratio0.93

Div yield—

Beta1.03

SKIN Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-56.57%

Price vs S&P 500 (4W)-20.45%

PEG Ratio0.93

VGM Score51.48

P/CF (Annual)1.83x

Book Value / Share (Quarterly)$0.43

P/TBV (Annual)7.01x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-6.32%

Cash Flow / Share (Quarterly)$0.13

Price vs S&P 500 (YTD)-73.94%

Gross Margin (TTM)68.83%

Net Profit Margin (TTM)-9.80%

EPS (TTM)$-0.22

10-Day Avg Trading Volume0.04M

EPS Excl Extra (TTM)$-0.22

Revenue Growth (5Y)20.36%

EPS (Annual)$-0.08

ROI (Annual)-2.24%

Gross Margin (Annual)67.68%

Net Profit Margin (5Y Avg)-33.82%

Cash / Share (Quarterly)$1.58

Revenue Growth QoQ (YoY)-7.77%

ROA (Last FY)-1.90%

Revenue Growth TTM (YoY)-6.46%

EBITD / Share (TTM)$-0.01

ROE (5Y Avg)-67.57%

Operating Margin (TTM)-1.14%

Cash Flow / Share (Annual)$0.25

P/B Ratio1.24x

P/B Ratio (Quarterly)1.62x

Net Income / Employee (Annual)$-15,500

EV / Revenue (TTM)0.72x

Net Interest Coverage (TTM)-0.30x

ROA (TTM)-5.79%

EV / EBITDA (TTM)18.77x

EPS Incl Extra (Annual)$-0.08

Current Ratio (Annual)1.66x

Quick Ratio (Quarterly)1.34x

3-Month Avg Trading Volume0.09M

52-Week Price Return-63.33%

EV / Free Cash Flow (Annual)6.43x

Revenue / Employee (TTM)$473,200

Tangible BV / Share (Quarterly)$0.19

P/S Ratio (Annual)0.23x

Asset Turnover (Annual)0.60x

52-Week High$34.80

Operating Margin (5Y Avg)-12.96%

EPS Excl Extra (Annual)$-0.08

CapEx CAGR (5Y)6.21%

26-Week Price Return-46.67%

Quick Ratio (Annual)1.37x

13-Week Price Return-37.44%

Total Debt / Equity (Annual)5.97x

Current Ratio (Quarterly)1.76x

Enterprise Value$207.85M

Revenue / Share Growth (5Y)-7.28%

Asset Turnover (TTM)0.59x

Revenue / Employee (Annual)$490,700

Inventory Turnover (Annual)1.66x

Pretax Margin (Annual)-1.97%

Cash / Share (Annual)$1.82

3-Month Return Std Dev76.65%

Gross Margin (5Y Avg)63.48%

Net Income / Employee (TTM)$-46,400

ROE (Last FY)-15.59%

Net Interest Coverage (Annual)-0.10x

EPS Basic Excl Extra (Annual)$-0.08

P/FCF (TTM)2.88x

Receivables Turnover (TTM)13.59x

EV / Free Cash Flow (TTM)12.49x

Total Debt / Equity (Quarterly)6.21x

EPS Incl Extra (TTM)$-0.22

Receivables Turnover (Annual)12.18x

ROI (TTM)-6.87%

P/S Ratio (TTM)0.24x

Pretax Margin (5Y Avg)-33.84%

Revenue / Share (Annual)$2.38

Tangible BV / Share (Annual)$0.20

Price vs S&P 500 (52W)-78.87%

Year-to-Date Return-62.01%

5-Day Price Return0.57%

EPS Normalized (Annual)$-0.08

ROA (5Y Avg)-8.65%

Net Profit Margin (Annual)-3.16%

Month-to-Date Return-16.19%

Cash Flow / Share (TTM)$-0.40

EBITD / Share (Annual)$0.01

Operating Margin (Annual)-0.90%

LT Debt / Equity (Annual)3.94x

P/CF (TTM)3.13x

ROI (5Y Avg)-10.20%

LT Debt / Equity (Quarterly)4.36x

EPS Basic Excl Extra (TTM)$-0.22

P/TBV (Quarterly)3.54x

P/B Ratio (Annual)2.90x

Inventory Turnover (TTM)1.71x

Pretax Margin (TTM)-8.18%

Book Value / Share (Annual)$0.48

Price vs S&P 500 (13W)-40.13%

Beta1.03x

P/FCF (Annual)2.13x

Revenue / Share (TTM)$2.24

ROE (TTM)-47.88%

52-Week Low$10.01

vGradeA

gGradeD

mGradeD

vgmGradeC

SKIN Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q2 2026	Aug 6, 2026	—	$1.57	—
Q1 2026	May 7, 2026	—	$0.62	—
Q4 2025	Mar 12, 2026	-$1.09	-$1.20	-10.07%(-$0.11)
Q3 2025	Nov 6, 2025	-$1.00	$0.57	+156.80%(+$1.57)
Q2 2025	Aug 7, 2025	-$0.02	$0.22	+1190.55%(+$0.24)

SKIN Analyst Recommendations

Jun 2026

Jul 2026

Aug 2026

Sep 2026

2.57

Industry Peers — Surgical & Medical Instruments(142)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth (5Y)	Gross Margin (TTM)	Operating Margin (TTM)	Price
SKINSkinHealth Systems Inc. Class A Common Stock	A	D	D	0.2x	20.4%	68.8%	-1.1%	$10.56
SYKStryker Corporation	C	B	C	4.4x	11.8%	65.3%	21.3%	$294.66
MMM3M Company	C	D	B	3.4x	-5.0%	39.4%	18.4%	$164.75
BSXBoston Scientific Corp.	C	B	C	3.1x	15.2%	69.5%	19.8%	$44.39
BDXBecton, Dickinson and Co.	B	D	A	2.5x	6.3%	46.7%	9.6%	$191.75
MDLNMedline Inc. Class A common stock	C	D	C	1.6x	—	26.2%	6.0%	$35.96
RMDResMed Inc.	C	C	B	5.9x	12.1%	61.1%	33.4%	$238.97
DXCMDexCom, Inc.	C	B	B	6.5x	19.3%	64.3%	22.9%	$86.04
WSTWest Pharmaceutical Services, Inc.	D	C	A	8.5x	7.4%	36.8%	20.4%	$384.02
SOLVSolventum Corporation	C	C	B	1.8x	—	54.8%	23.9%	$85.81
BAXBaxter International Inc.	B	D	B	1.1x	-0.8%	30.7%	-2.3%	$25.28
PENPenumbra, Inc.	F	C	B	8.4x	20.2%	67.8%	12.4%	$320.86
GMEDGLOBUS MEDICAL INC	B	B	B	3.3x	30.1%	68.5%	20.6%	$76.71
PODDInsulet Corporation	C	A	C	3.2x	24.5%	71.1%	16.9%	$141.10
GKOSGlaukos Corporation	F	A	B	15.9x	17.7%	79.1%	-31.6%	$164.84
TFXTeleflex Incorporated	B	F	B	2.1x	-4.7%	53.8%	-11.7%	$130.43
HAEHaemonetics Corporation	C	C	A	4.0x	8.9%	59.1%	11.9%	$118.28
MMSIMerit Medical Systems Inc	C	B	B	3.4x	9.5%	49.5%	12.8%	$89.20
STVNStevanato Group S.p.A.	D	C	C	3.7x	12.4%	29.9%	16.4%	$18.90
MMEDMiniMed Group, Inc. Common Stock	—	—	B	—	—	—	—	$17.49
HTFLHeartflow, Inc. Common Stock	F	A	A	19.8x	—	80.1%	-40.8%	$48.29
ICUIICU Medical Inc	C	D	B	1.9x	11.9%	39.1%	3.5%	$162.99
IRTCiRhythm Holdings, Inc. Common Stock	D	B	C	4.3x	23.0%	71.5%	-3.0%	$108.66
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	2725.9x	—	0.3%	-7007.8%	$44.43
ATRCAtriCure, Inc.	D	B	A	5.0x	20.9%	76.3%	2.3%	$56.07
UFPTUFP Technologies Inc	C	B	A	3.6x	27.4%	28.5%	15.3%	$291.67
INSPInspire Medical Systems, Inc.	B	B	B	2.2x	51.2%	86.1%	6.0%	$68.79
LMATLeMaitre Vascular, Inc.	C	B	C	7.0x	14.0%	72.9%	29.5%	$80.82
NVCRNovoCure Limited Ordinary Shares	D	C	C	2.3x	5.8%	76.1%	-22.1%	$14.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	15.2x	—	53.9%	-140.4%	$27.24
ATECAlphatec Holdings, Inc.	D	B	C	2.0x	39.5%	70.8%	-7.5%	$10.46
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	B	—	—	—	—	$12.29
TNDMTandem Diabetes Care, Inc.	D	C	C	1.1x	15.3%	56.0%	-4.4%	$16.24
IRMDiRadimed Corporation	D	B	B	13.1x	21.4%	75.9%	31.9%	$88.27
AORTArtivion, Inc.	C	C	C	2.3x	11.8%	64.4%	2.9%	$21.78
IARTIntegra LifeSciences Holdings	B	F	C	0.6x	3.6%	57.2%	4.0%	$13.21
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	3.0x	109.0%	64.2%	-33.9%	$17.57
BVSBioventus Inc. Class A Common Stock	B	C	A	1.9x	12.1%	68.7%	10.0%	$13.30
BBNXBeta Bionics, Inc. Common Stock	D	A	C	7.4x	—	58.3%	-69.8%	$16.35
SIBNSI-BONE, Inc. Common Stock	D	B	B	4.1x	22.3%	79.5%	-8.3%	$19.68
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	—	—	—	—	$24.00
MDXGMiMedx Group, Inc	C	D	C	1.8x	11.0%	78.8%	2.5%	$4.43
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	2.3x	27.2%	73.7%	-11.9%	$21.95
TCMDTactile Systems Technology, Inc.	B	B	B	1.5x	12.0%	51.9%	10.0%	$22.52
SSIISS Innovations International Inc. Common Stock	F	A	D	9.7x	—	47.6%	-16.2%	$2.53
DCTHDelcath Systems Inc	D	C	B	5.1x	120.1%	87.0%	-1.9%	$14.08
ANGOAngioDynamics, Inc.	C	D	C	1.5x	1.9%	55.6%	-11.2%	$11.24
BWAYBrainsway Ltd. American Depositary Shares	D	B	B	9.5x	12.2%	74.9%	5.8%	$11.44
SGHTSight Sciences, Inc. Common Stock	D	B	A	5.5x	22.9%	88.4%	-33.4%	$8.28
CERSCerus Corp	D	C	C	1.8x	15.4%	57.2%	-0.7%	$2.18
NPCENeuropace, Inc. Common Stock	D	C	C	4.3x	19.4%	79.6%	-15.3%	$12.24

About SkinHealth Systems Inc. Class A Common Stock

The Beauty Health Company designs and manufactures aesthetic technology platforms for professional beauty treatments. Its brand portfolio includes Hydrafacial for skin resurfacing, SkinStylus for microneedling, and Keravive for scalp care, with revenue generated through device sales and recurring consumables.

SKIN Next Earnings Report

Report dateNov 5, 2026

QuarterQ3 2026

Report timeAMC

EPS estimate$0.00

Revenue estimate$67.93M

Also reporting on Nov 5, 2026

Scheduled date with consensus estimates — both can change before the company reports.

Earnings calendar for November 2026

Companies in Related Industries

HYPRHyperfine, Inc. Class A Common StockElectromedical Equipment
NTRBNutriband Inc. Common StockOrthopedic & Prosthetic Devices
OMOutset Medical, Inc. Common StockElectromedical Equipment
ECORelectroCore, Inc. Common StockElectromedical Equipment
OPXSOptex Systems Holdings, INCOptical Instruments & Lenses
SPAISafe Pro Group Inc. Common StockOrthopedic & Prosthetic Devices
GEOSGeospace Technologies Corporation Common StockMeasuring & Controlling Devices
APTAlpha Pro Tech, Ltd.Orthopedic & Prosthetic Devices

Same SIC sector, outside this company's own industry.

Analyst Sentiment

2.6

Sell

Consensus rating

52-Week Range

Low$10.01

High$34.80